Clinical Markers Improve With IV Ertapenem for Hidradenitis Suppurativa
Significant reductions seen in mean Physician Global Assessment scores and in pain, C-reactive protein, IL-6, leukocytes
This Election Year, Health Care Costs Top Voter Concerns: Poll
Amtagvi Approved by the FDA for Treatment of Advanced Melanoma
Agency approves one-time cell therapy for patients who have progressed after initial standard-of-care therapies
Expanded Use of Xolair to Treat Food Allergies Approved by the FDA
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen
Deep Learning Improves Diagnostic Accuracy for Skin Diseases
Both specialists and generalists were 4 percentage points less accurate for diagnosis of images of dark versus light skin
FDA Approves Aurlumyn for Severe Frostbite
Newly approved medication lowers the need for amputation of fingers or toes
Study Looks at Access to U.S. Burn Centers Using 2019 Data
Disparities seen in access to burn centers, with lower access in the South and West and for those with lower income
Link Between Inflammatory Disease, Adverse Pregnancy Outcomes Varies
Patients with IMIDs had increased risk for PTB, LBW, SGA, C-section overall, but variation seen by disease, comorbidities
Smoking Linked to Melanoma-Associated Death in Early-Stage Melanoma
Greatest increased risk for melanoma-specific mortality seen for patients with SLNB-negative disease
JNJ-77242113 Shows Greater Efficacy Than Placebo for Plaque Psoriasis
Percentage of patients with PASI-75 response was higher with the interleukin-23-receptor antagonist peptide
